NOX 5.71% 6.6¢ noxopharm limited

Ann: US FDA grants Orphan Drug Designation for CRO-67, page-2

  1. 6,170 Posts.
    lightbulb Created with Sketch. 1215
    The apparently very short time interval between NOX reporting the preliminary results for treatment of pancreatic cancer and FDA Orphan drug status is remarkable. Looks like the FDA sees this treatment as a potential significant breakthrough and have wasted no time in granting the Orphan Status
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.004(5.71%)
Mkt cap ! $19.28M
Open High Low Value Volume
7.6¢ 7.6¢ 6.6¢ $3.396K 49.28K

Buyers (Bids)

No. Vol. Price($)
2 57227 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 11999 1
View Market Depth
Last trade - 10.52am 05/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.